Home/ Stocks/ ETON

Eton Pharmaceutcials, Inc. Common Stock

ETON XNAS

$29.65 -1.37 (-4.42%) ▼ 15-min delayed

Open

$30.93

High

$30.93

Low

$29.29

Volume

284.7K

Market Cap

$811.22M

About Eton Pharmaceutcials, Inc. Common Stock

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 44 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$79.95M	$-4,601,000	$-0.17
FY 2025	$79.95M	$-4,601,000	$-0.17
Q3 2025	$22.46M	$-1,927,000	$-0.07
Q2 2025	$18.93M	$-2,585,000	$-0.10

Related Market News

No specific coverage for ETON yet. Check out our latest market news or earnings calendar.

Get ETON Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Eton Pharmaceutcials, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.